Last Updated on December 31, 2023 by The Health Master
National Policy for R&D
Download the R&D Incentive Scheme for the Pharma Industry, the link is given below: In a significant development, Union Health Minister Dr. Mansukh Mandaviya announced that India is on the brink of introducing a comprehensive national policy designed to invigorate research, development, and innovation within the pharmaceutical and medical device sectors.
At the G20 health ministers meeting, which took place from August 17 to August 19, Mandaviya gave the keynote address.
Leaders of the Indian pharmaceutical industry and delegates from other G20 countries were present.
Commitment to Quality Healthcare Amidst Global Challenges
Amid the tumultuous backdrop of the COVID-19 pandemic, Minister Mandaviya underscored India’s unwavering commitment to providing quality, accessible, and affordable healthcare.
He lauded India’s remarkable efforts during the pandemic, which demonstrated the nation’s dedication to supporting the health and well-being of its citizens.
Shifting Paradigms in Healthcare Leadership
Central to India’s future healthcare vision is a transformative shift from volume-based approaches to a value-driven leadership model.
Minister Mandaviya emphasized this shift, highlighting how India aims to ensure healthcare services are not just abundant in quantity, but also deliver value and excellence to patients.
National policy: Empowering Innovation in Healthcare Advancement
Recognizing the pivotal role of research and development in advancing healthcare, Minister Mandaviya revealed India’s strides in fostering an innovative environment.
He revealed that the nation is in the final stages of implementing a national policy that will stimulate research, development, and innovation within the pharmaceutical and medical devices sectors.
This National policy is poised to act as a catalyst for transformative advancements in healthcare technology and treatments.
Global Collaboration for Unprecedented Growth
In a resounding call to action, Minister Mandaviya invited countries, government bodies, industry leaders, healthcare professionals, and researchers to join forces in elevating the pharmaceutical and medical device sectors to new heights of innovation and excellence.
This collective effort is set to drive unparalleled growth and cooperation within the global healthcare community.
Global Leaders Acknowledge India’s Prowess
Minister Mandaviya’s message was reinforced by esteemed global health ministers.
The Minister of Health for the Republic of Indonesia, Budi G Sadikin, and the Health Minister of the Netherlands, Dr. Ernst Kuipers, both acknowledged India’s remarkable achievements in health and pharmacology.
They emphasized the crucial need for international collaboration and partnerships to further advance healthcare standards and innovation.
India’s Model for Affordable Medicines Garners Praise
The success of India’s pharmaceutical industry resonated strongly during the meeting.
Dr. Kuipers noted that medicines manufactured in India have saved countless lives across the world, underscoring the potential for deepened collaboration in the realm of innovative medicines.
The Indian model for providing affordable and high-quality medicines also drew admiration from Dr. Sadikin of Indonesia, who expressed a keen interest in replicating India’s Jan Aushadhi Kendra model.
Jan Aushadhi Kendra: A Model of Excellence
Mandaviya led a delegation of G20 delegates and ministers, including the Indonesian health minister, to a Jan Aushadhi Kendra—an Indian initiative offering accessible, affordable, and quality medicines to citizens.
Dr. Sadikin expressed his intent to replicate this model in Indonesia, stating that India’s Jan Aushadhi Kendra stands as a beacon of quality, accessibility, and affordability in healthcare services.
Looking Ahead: A Promising Future
As discussions continue on the success of the Jan Aushadhi Kendra model, Minister Mandaviya emphasized the global recognition it has garnered for its cost-effective and quality-focused approach.
Amidst rising healthcare costs worldwide, the Indian model has emerged as a beacon of hope and innovation, exemplifying the potential for collaborative efforts to transform healthcare accessibility and affordability on a global scale.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model, to rewrite and present the news / article in a unique format.
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Understanding GMP, cGMP, and WHO-GMP
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Dissolution test: Importance in Pharma Industry
NSQ Drug: Route cause analysis and CAPA
Types of inspections done by USFDA: Read in detail
USFDA issues Form 483 to Pharma Companies: Let’s know all about it
Procedure to obtain license for manufacturing of Medical Devices
Procedure for registration of Medical Devices: CDSCO
Registration for sale of Medical Devices: Procedure and conditions
Latest Notifications: Medical Devices
Classifications of Medical Devices under the provisions of MDR 2017
Notified Bodies for Medical Devices
Updated list of Notified Bodies for Medical Devices
Updated list of Medical Device Testing Laboratories (MDTLs)
Forms: All types of Medical Devices
Schedules: All types of Medical Devices
FAQs on Medical Devices Rules, 2017
USFDA gives approval for this drug to treat Rare Blood Disease
India launches Rs 5,000 Crore R&D Incentive Scheme for Pharma Industry
Major FDA audit findings about Equipment and Instruments
DCGI issued alert for falsified this diabetes management drugs
Govt collaborates with Pharma Industry to lower prices of Rare Disease Medicines
Procedural lapses flagged at Aurobindo Pharma by USFDA: Telangana
USFDA gives nod for Potassium Chloride for Injection Concentrate
Pharma Company Manager arrested for supplying Banned Drugs
The Controversy Surrounding Generic Drug Prescription
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
